M&A Deal Summary

Cinven Acquires Envu

On March 10, 2022, private equity firm Cinven acquired environmental company Envu from Bayer for 2.6B USD

Acquisition Highlights
  • This is Cinven’s 1st transaction in the Environmental sector.
  • This is Cinven’s 10th largest (disclosed) transaction.
  • This is Cinven’s 19th transaction in the United States.
  • This is Cinven’s 5th transaction in North Carolina.

M&A Deal Summary
Date 2022-03-10
Target Envu
Sector Environmental
Buyer(s) Cinven
Sellers(s) Bayer
Deal Type Divestiture
Deal Value 2.6B USD

Target

Envu

Cary, North Carolina, United States
Envu is a global provider of products and services to create healthier environments, to manage pests, and to eliminate vector-borne diseases, across a range of end-markets. Envu has an extensive product portfolio to manage pests (such as rodents, pest insects and invasive weeds) in a sustainable and responsible manner, including for the vegetation management, range and pasture, forestry and turf and ornamentals markets. In addition, the business markets products to protect against vector-borne diseases such as malaria, and to promote public health objectives in the developing world. Envu is headquartered in Cary, North Carolina.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cinven

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1977
PE ASSETS 39.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cinven is a private equity firm focused on buyout investments in growing, profitable businesses located throughout Europe and North America. Sectors of interest include business and financial services, healthcare, industrial, retail, leisure, consumer, technology, media, and telecommunications. Cinven looks to invest a minimum of €200 million in companies with minimum enterprise values of €400 million. Cinven does not invest in start-ups or development phase companies. Cinven was established in 1977 and is headquartered in London.

DEAL STATS #
Overall 176 of 184
Sector (Environmental) 1 of 1
Type (Divestiture) 34 of 35
State (North Carolina) 5 of 5
Country (United States) 19 of 20
Year (2022) 2 of 4
Size (of disclosed) 10 of 62
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-01 IFGL

Isle of Man, United Kingdom

IFGL is a specialist international life assurance provider, offering a range of savings and investment products within a life assurance wrapper, affording capital protection and investment flexibility. IFGL was founded in 2009 and is based in Isle of Man, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-03 Premium Credit

Surrey, United Kingdom

Premium Credit is a provider of premium finance for commercial and retail insurance products. PCL’s products are a key source of funding for consumers and smaller businesses in the purchase of often mandatory products, such as motor, home or fire insurance. The company also provides financing for the payment of annual fees such as membership subscriptions, professional fees, commercial service charges and school fees. Premium Credit was founded in 1988 and is based in Surrey, United Kingdom.

Sell -

Seller(S) 1

SELLER

Bayer

Leverkusen, Germany
Category Company
Founded 1863
Sector Life Science
Employees98,189
Revenue 47.6B EUR (2023)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 19 of 23
Sector (Environmental) 1 of 1
Type (Divestiture) 15 of 19
State (North Carolina) 1 of 1
Country (United States) 6 of 7
Year (2022) 1 of 3
Size (of disclosed) 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-05 Vividion Therapeutics

San Diego, California, United States

Vividion Therapeutics is a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics. Vividion Therapeutics is based in San Diego, California.

Buy $1.5B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-14 Nebido

Leverkusen, Germany

Nebido provides treatment of male hypogonadism (testosterone deficiency) is based in Leverkusen, Germany.

Sell €500M
Mergr

Product

Company

Legal